
The impact of changes in the source population of patients for cancer clinical trials in the USA is zzso The first change, which has already taken place, is the recent trend of including patients treated of community hospitals in cooperative group and other zzso zzso This change was designed to augment zzso to studies, and to zzso state-of-the-art information on patient zzso The change has been shown to be a successful one, with community hospitals providing high quality participation in the zzso In addition, the research protocols have been seen to influence the care of many patients treated zzso The inclusion of community hospitals in the trials zzso our understanding of the zzso of the results of the zzso The issue of zzso is, however, obscured by the fact that the great majority of cancer patients are not treated on zzso zzso most of them are ineligible for zzso The rationale for strict eligibility is unclear in many cases, and its use greatly reduces zzso and casts doubt on the zzso of zzso In the future, more care should be paid to the selection of the source population for clinical zzso 

